Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

Press releases published on September 28, 2026

4 hours ago

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

Indeterminate GlobeNewswire

4 hours ago

BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team

Indeterminate GlobeNewswire

4 hours ago

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

4 hours ago

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

Indeterminate GlobeNewswire

4 hours ago

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Indeterminate GlobeNewswire

4 hours ago

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Indeterminate GlobeNewswire

4 hours ago

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

Indeterminate GlobeNewswire

4 hours ago

NOTICE TO DISREGARD -- Direct Meds

Indeterminate GlobeNewswire

5 hours ago

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

Indeterminate GlobeNewswire

5 hours ago

Flyte Named Official Air Travel Partner of the 34th Annual Hamptons International Film Festival

Indeterminate GlobeNewswire

5 hours ago

MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

Indeterminate GlobeNewswire

5 hours ago

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Indeterminate GlobeNewswire

6 hours ago

Lift Therapeutics Appoints Eva Ehrnrooth as Executive Head of Clinical Development and Adds Chau Khuong to Board of Directors

Indeterminate GlobeNewswire

7 hours ago

إطلاق نهج طبي دولي جديد رسمياً في شنتشن بالصينيهدف إلى عكس مسار السكري

Indeterminate GlobeNewswire

7 hours ago

A New International Medical Approach Aimed at Reversing Diabetes has Officially Launched in Shenzhen, China

Indeterminate GlobeNewswire

8 hours ago

Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno

Indeterminate GlobeNewswire

8 hours ago

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

Indeterminate GlobeNewswire

9 hours ago

Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

9 hours ago

Inventiva publie ses résultats financiers non audités du premier semestre 2026 et fait le point sur ses activités

Indeterminate GlobeNewswire

9 hours ago

OSE Immunotherapeutics Reports its Cash Position as of June 30, 2026, and Provides Business Update

Indeterminate GlobeNewswire